Sedana Medical AB (publ) (FRA:7D2A)

Sedana Medical AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	200.23	178.75	153.87	122.87	159.15
Revenue Growth (YoY)	12.01%	16.17%	25.23%	-22.80%	12.26%
Cost of Revenue	57.52	52.61	44.89	36.79	52.45
Gross Profit	142.71	126.14	108.98	86.07	106.71
Selling, General & Admin	154.66	156.6	154.74	169.94	148.31
Research & Development	20.62	20.29	20.81	19.94	19.7
Other Operating Expenses	0.25	0.03	-0.02	0.12	-0.11
Operating Expenses	175.52	176.92	175.53	190.01	167.9
Operating Income	-32.82	-50.78	-66.55	-103.93	-61.2
Interest Expense	-3.38	-0.18	-0.22	-0.26	-0.24
Interest & Investment Income	-	16.49	15.17	3.58	-
Currency Exchange Gain (Loss)	-22.48	24.52	-7.42	27.68	4.07
Other Non Operating Income (Expenses)	1.41	-0	-	-	-
Pretax Income	-57.26	-9.95	-59.02	-72.93	-57.37
Income Tax Expense	1.98	0.73	0.59	0.57	0.6
Net Income	-59.24	-10.67	-59.61	-73.51	-57.97
Net Income to Common	-59.24	-10.67	-59.61	-73.51	-57.97
Shares Outstanding (Basic)	99	99	99	99	93
Shares Outstanding (Diluted)	99	99	99	99	93
Shares Change (YoY)	-	-	-	6.85%	1.54%
EPS (Basic)	-0.60	-0.11	-0.60	-0.74	-0.62
EPS (Diluted)	-0.60	-0.11	-0.60	-0.74	-0.62
Free Cash Flow	-15.18	-13.99	-38.58	-116.17	-46.41
Free Cash Flow Per Share	-0.15	-0.14	-0.39	-1.17	-0.50
Gross Margin	71.27%	70.57%	70.83%	70.06%	67.05%
Operating Margin	-16.39%	-28.41%	-43.25%	-84.59%	-38.45%
Profit Margin	-29.59%	-5.97%	-38.74%	-59.83%	-36.42%
Free Cash Flow Margin	-7.58%	-7.82%	-25.07%	-94.55%	-29.16%
EBITDA	-10.78	-48.77	-64.19	-100.56	-56.8
EBITDA Margin	-5.38%	-27.28%	-41.72%	-81.84%	-35.69%
D&A For EBITDA	22.04	2.01	2.36	3.38	4.4
EBIT	-32.82	-50.78	-66.55	-103.93	-61.2
EBIT Margin	-16.39%	-28.41%	-43.25%	-84.59%	-38.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.